Filing Details
- Accession Number:
- 0001003642-17-000064
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-01 14:36:49
- Reporting Period:
- 2017-05-31
- Filing Date:
- 2017-06-01
- Accepted Time:
- 2017-06-01 14:36:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1003642 | Impax Laboratories Inc | IPXL | Pharmaceutical Preparations (2834) | 650403311 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1196063 | Michael Nestor | C/O Impax Laboratories, Inc. 30831 Huntwood Avenue Hayward CA 94544 | President, Impax Specialty | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-05-31 | 1,130 | $15.00 | 106,943 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
